Dr. Hassan is a distinguished scientist internationally recognized for his pioneering work in the field of infectious diseases, particularly in the development of novel antiviral therapeutics targeting human herpesvirus infections. His scientific endeavors are complemented by a deep commitment to advancing medical knowledge and improving public health outcomes.

Beyond his laboratory achievements, Dr. Hassan plays an active role in the global scientific community. He serves on the editorial boards of several high-impact international journals indexed in Web of Science (Clarivate) and Scopus, reflecting his reputation as a trusted authority in virology, antiviral pharmacology, molecular medicine, microbiology, and immunology. He is also an active member of various international scientific societies related to virology and pharmacology, further demonstrating his engagement with the broader biomedical research community. A comprehensive overview of his scholarly contributions can be found on his ORCID profile (https://orcid.org/0000-0003-3922-2738).

Dr. Hassan’s expertise has earned him invitations to serve as an organizing committee member and keynote speaker at numerous national and international conferences and symposia. His contributions have taken him to a wide array of countries—including the Czech Republic, Slovak Republic, Austria, Switzerland, France, Italy, Belgium, England, Spain, Canada, Brazil, Singapore, United Arab Emirates, and Malaysia—where he has shared his innovative research, fostered interdisciplinary collaboration, and inspired scientific dialogue aimed at addressing some of the most pressing challenges in infectious disease research and antiviral therapy.

In recognition of his outstanding scientific achievements and international impact, Dr. Hassan has received several prestigious international scientific awards, further underscoring his leadership and innovation in the field.